Brevan Howard Capital Management LP Emergent Bio Solutions Inc. Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 13,900 shares of EBS stock, worth $140,529. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,900
Previous 18,724
25.76%
Holding current value
$140,529
Previous $119,000
2.52%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding EBS
# of Institutions
192Shares Held
41.3MCall Options Held
899KPut Options Held
256K-
Black Rock Inc. New York, NY3.84MShares$38.8 Million0.0% of portfolio
-
Oak Hill Advisors LP New York, NY3.61MShares$36.5 Million3.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.54MShares$35.8 Million0.0% of portfolio
-
State Street Corp Boston, MA2.45MShares$24.7 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.38MShares$24.1 Million0.01% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $504M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...